What versions of Opicapone are available? Differences and Choices between Original Drugs and Generic Drugs

Opicapone (Opicapone) is a drug used for the auxiliary treatment of Parkinson's disease and belongs to the COMT inhibitor class of drugs. Its main mechanism of action is to inhibit the activity of catechol-O-methyltransferase (COMT) and prolong the half-life of levodopa (Levodopa), thereby improving the "switch" fluctuation symptoms of patients with Parkinson's disease. At present, Opicapone has not yet been officially launched in mainland China, so patients who need to use the drug mainly rely on overseas channels to purchase drugs.

In the current international market, the pharmaceutical version of Opicapone is relatively limited. Currently, there is only a version of the original drug developed and launched by the Portuguese pharmaceutical company BIAL. The drug has obtained marketing approval in many European countries and entered the market in the United States under the trade name "ONGENTYS". These original drugs have high quality standards, stable efficacy, and fully verified safety, and are deeply trusted by doctors and patients. According to market information, the price of European original drugs is about more than 2,000 yuan per box, which is relatively high due to the costs involved in imports, channels, etc.

At present, there is no generic version of Opicapone, which means that no other country or pharmaceutical company has launched a substitute with the same ingredients but lower price on the market. Compared with some other common Parkinson's disease adjuvant drugs, Opicapone's market coverage and generic drug progress are slower, which may be related to its patent protection, complexity of the production process and relatively new time on the market. Therefore, when patients choose Opicapone, they can only purchase the original version.

Generally speaking, when choosing Opicapone, since there is currently only one version of the original drug, patients do not need to face the problem of comparative selection between the original drug and generic drugs. However, due to the high price of medicines and the need to obtain them through overseas channels, patients are advised to consult a professional doctor before purchasing and choose a regular pharmaceutical service organization to ensure that the source of medicines is reliable and the quality is guaranteed. In the future, if generic drug versions are gradually launched, patients may be able to obtain treatment solutions with the same ingredients at more affordable prices.

Reference materials:https://www.ongentys.com/